Showing results (41-50 of 269) with videos related to

Sort By:
Pageof 27
Clinical Breast Cancer|May 27, 2008
Letrozole versus letrozole plus Lapatinib (GW572016) in hormone-sensitive, HER2-negative operable breast cancer: a double-blind, randomized, phase II study with biomarker evaluation (EGF109077-LAP107692/LETLOB)Antonio Frassoldati, Valentina Guarneri, Federico Piacentini, et al.
Critical Reviews in Oncology/Hematology|February 21, 2024
The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategiesAlessandra Ferro, Gian Marco Marinato, Cristiana Mulargiu, et al.
Cancer Treatment Reviews|May 26, 2024
The emerging role of Schlafen-11 (SLFN11) in predicting response to anticancer treatments: Focus on small cell lung cancerDaniela Scattolin, Alessandro Dal Maso, Alessandra Ferro, et al.
Breast (Edinburgh, Scotland)|July 6, 2025
Omitting anthracyclines for the adjuvant treatment of patients with triple-negative breast cancer: A non-inferiority meta-analysisFabio Girardi, Caterina Barbieri, Gaia Griguolo, et al.
Critical Reviews in Oncology/Hematology|June 4, 2021
Treatment strategies for locally advanced non-small cell lung cancer in elderly patients: Translating scientific evidence into clinical practiceLaura Bonanno, Ilaria Attili, Alberto Pavan, et al.
Cancers|November 13, 2020
Therapeutic Strategies for the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive (HR+/HER2+) Breast Cancer: A Review of the Current LiteratureEirini Thanopoulou, Leila Khader, Morena Caira, et al.
Frontiers in Oncology|March 26, 2024
Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reportsLoc Carlo Bao, Alessia Padovan, Andrea Boscolo Bragadin, et al.
Annals of Palliative Medicine|July 24, 2022
Induction chemotherapy with carboplatin and paclitaxel for thymoma in acute respiratory distress due to myasthenia gravis: a case reportGiovanni Maria Comacchio, Beatrice Benetti, Elisabetta Di Liso, et al.
Cancer Treatment Reviews|May 24, 2020
Real world data in the era of Immune Checkpoint Inhibitors (ICIs): Increasing evidence and future applications in lung cancerGiulia Pasello, Alberto Pavan, Ilaria Attili, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2024
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast CancerMichele Bottosso, Federica Miglietta, Grazia Maria Vernaci, et al.
Pageof 27